Abstract:Doxorubicin (DOX) is one of the most commonly used anticancer drugs; however, its clinical application is greatly limited due to its toxicity and chemotherapy resistance. The delivery of DOX by liposomes (Lipos) can improve the blood circulation time in vivo and reduce toxic side effects, but the drug's accumulation in the tumor is often insufficient for effective treatment. In this study, we present a calcium cross-linked liposome gel for the encapsulation of DOX, demonstrating its superior long-term release capabilities compared to conventional Lipos. By leveraging this enhanced long-term release, we can enhance drug accumulation within tumors, ultimately leading to improved antitumor efficacy. Lipos were prepared using the thin-film dispersion method in this study. We utilized the ion-responsiveness of glutathione-gelatin (GSH-GG) to form the gel outside the Lipos and named the nanoparticles coated with GSH-GG on the outside of Lipos as Lipos@GSH-GG. The average size of Lipos@GSH-GG was around 342.9 nm, with a negative charge of -25.6 mV. The in vitro experiments revealed that Lipos@GSH-GG exhibited excellent biocompatibility and slower drug release compared to conventional Lipos. Further analysis of cellular uptake and cytotoxicity demonstrated that Lipos@GSH-GG loading DOX (DOX&Lipos@GSH-GG) exhibited superior long-term release effects and lower toxic side effects compared to Lipos loading DOX (DOX&Lipos). Additionally, the findings regarding the long-term release effect in vivo and the tumor accumulation within tumor-bearing mice of Lipos@GSH-GG suggested that, compared to Lipos, it demonstrated superior long-term release capabilities and achieved greater drug accumulation within tumors. In vivo antitumor efficacy experiments showed that DOX&Lipos@GSH-GG demonstrated superior antitumor efficacy to DOX&Lipos. Our study highlights Lipos@GSH-GG as a promising nanocarrier with the potential to enhance efficacy and safety by means of long-term release effects and may offer an alternative approach for effective antitumor therapy in the future.

Doxorubicin-loaded PLGA Microparticles with Internal Pores for Long-Acting Release in Pulmonary Tumor Inhalation Treatment

Inhalable Functional Mixed-Polymer Microspheres to Enhance Doxorubicin Release Behavior for Lung Cancer Treatment

Doxorubicin-loaded star-shaped copolymer PLGA-vitamin E TPGS nanoparticles for lung cancer therapy

Synergistic co-delivery of doxorubicin and paclitaxel by porous PLGA microspheres for pulmonary inhalation treatment.

Combination of Doxorubicin-Based Chemotherapy and Polyethylenimine/p53 Gene Therapy for the Treatment of Lung Cancer Using Porous PLGA Microparticles.

Improving the Intracellular Drug Concentration in Lung Cancer Treatment Through the Codelivery of Doxorubicin and Mir-519c Mediated by Porous Plga Microparticle

Porous PLGA Microparticles to Encapsulate Doxorubicin and Polyethylenimine/mir-34A for Inhibiting the Proliferation and Migration of Lung Cancer

Novel PLGGE Graft Polymeric Micelles for Doxorubicin Delivery

Biodegradable Interlayer-Crosslinked Polymer Micelles with Reduction Sensitivity for Non-Small Cell Lung Cancer Therapy.

Pulmonary Delivery by Exploiting Doxorubicin and Cisplatin Co-Loaded Nanoparticles for Metastatic Lung Cancer Therapy

Matrix metalloproteinase 2/9-triggered-release micelles for inhaled drug delivery to treat lung cancer: preparation and in vitro/in vivo studies.

Doxorubicin Loaded Liposomes for Lung Tumor Targeting: in Vivo Cell Line Study in Human Lung Cancer.

CD44/Folate Dual Targeting Receptor Reductive Response PLGA-Based Micelles for Cancer Therapy

Nanoscaled Poly(l-Glutamic Acid)/doxorubicin-Amphiphile Complex As Ph-Responsive Drug Delivery System for Effective Treatment of Nonsmall Cell Lung Cancer.

Biodegradable Chitosan/alginate BSA-gel-capsules for Ph-Controlled Loading and Release of Doxorubicin and Treatment of Pulmonary Melanoma.

PEGylated-PLGA Nanoparticles Coated with Ph-Responsive Tannic Acid-Fe(III) Complexes for Reduced Premature Doxorubicin Release and Enhanced Targeting in Breast Cancer.

Bioreducible Paa-G-Peg Graft Micelles with High Doxorubicin Loading for Targeted Antitumor Effect Against Mouse Breast Carcinoma

Formulation and Process Optimization of Doxorubicin-Loaded PLGA Nanoparticles and Its in Vitro Release

Design of gefitinib-loaded PLGA microspheres via microfluidics for lung cancer

Highly Loaded Deoxypodophyllotoxin Nano-Formulation Delivered by Methoxy Polyethylene Glycol-Block-poly (D,l-Lactide) Micelles for Efficient Cancer Therapy.

Preparation of Liposome Gel by Calcium Cross-Linking Induces the Long-Term Release of DOX to Improve the Antitumor Effect